OSIR:
Analysis & Opinions
-
November 27, 2012
Pluristem Therapeutics, Inc. (PSTI) recently provided an update on its efforts to gain orphan drug status for its ...
-
November 07, 2012
Osiris Therapeutics Inc. (OSIR) reported a third quarter loss of 9 cents per share, narrower than the Zacks ...
-
October 01, 2012
Osiris Therapeutics, Inc. (OSIR) recently announced that it has regained global rights to Prochymal and Chondrogen ...
-
July 03, 2012
Osiris Therapeutics, Inc. (OSIR) recently reported encouraging data from a study that evaluated its stem cell ...
-
June 22, 2012
We recently reiterated our Neutral recommendation on Osiris Therapeutics, Inc. (OSIR). Osiris, a stem cell ...
-
June 18, 2012
Just a few weeks after gaining approval in Canada, Osiris Therapeutics, Inc.'s (OSIR) stem cell therapy, Prochymal, ...
-
June 15, 2010
Stem cells get a lot of attention, but maybe not in the one area where they could prove most effective.
